“The global nasal drug delivery technology market is estimated to have reached $44,385 million in 2019” says new Visiongain report

30 March 2020
Pharma

Visiongain has launched a new pharma report Nasal Drug Delivery Technology Market Forecast 2020-2030: Nasal Sprays: Non-Pressurised Containers & Pressurised Containers, Nasal Drops & Liquids, Nasal Gels, Nasal Powders; Multi Dose Nasal Devices, Bi-Dose Nasal Devices, Unit Dose Nasal Devices; Allergic and Non-Allergic Rhinitis, Nasal Congestion, Asthma; Ambulatory Surgery Centres, Hospitals, Specialty Clinics, Vaccination Centres.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 185-page report you will receive 47 tables and 54 figures- all unavailable elsewhere.

The 185-page report provides clear detailed insight into the global nasal drug delivery technology market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Nasal Drug Delivery Technology Market forecasts from 2020-2030

• Global Nasal Drug Delivery Technology Market forecasts from 2020-2030 by Dosage Form:
• Nasal Sprays
• Non-Pressurized Containers
• Pressurized Containers
• Nasal Drops & Liquids
• Nasal Gels
• Nasal Powders

• Global Nasal Drug Delivery Technology Market Forecast 2020-2030 by System:
• Unidose Nasal Devices
• Bi-dose Nasal Devices
• Multi dose Nasal Devices

• Global Nasal Drug Delivery Technology Market forecasts from 2020-2030 by Application:
• Allergic and Non-Allergic Rhinitis
• Nasal Congestion
• Asthma

• Global Nasal Drug Delivery Technology Market forecasts from 2020-2030 by End User:
• Ambulatory Surgery Centers
• Hospitals
• Specialty Clinics
• Vaccination Centers

• Revenue forecasts for the Nasal Drug Delivery Technology Market by Regional and National Market from 2020-2030:
• North America: US, Canada, Mexico
• Latin America: Brazil, Mexico, Rest of Latin America
• Western Europe: Germany, UK, Italy, France, Spain, Nordic, Benelux, Rest of o Western Europe
• Eastern Europe: Russia, Poland, Rest of Eastern Europe
• Asia-Pacific: Japan, China, India, Australia & New Zealand, ASEAN, Rest of Asia-Pacific
• MEA: GCC Countries, South Africa, North Africa, Rest of MEA

The revenues forecast of each regional market is further broken down by wound type, product type, and end-user.

• Profiles and discussion on the leading companies of the nasal drug delivery technology market:
• 3M Company
• Becton, Dickinson and Company
• GlaxoSmithKline plc
• Johnson & Johnson
• Merck & Co., Inc.
• Pfizer Inc.
• Teleflex Incorporated
• Naveh Pharma Ltd.
• OptiNose US, Inc.
• Pendopharm
• AptarGroup, Inc.

• Analysis of the Drivers, Restraints, Opportunities and Trends of the wound care management market.

• Key Questions Answered by this Report:
• How is the nasal drug delivery technology market evolving?
• What is driving and restraining nasal drug delivery technology market dynamics?
• How will each nasal drug delivery technology submarket segment grow over the forecast period and how much Sales will these submarkets account for in 2030?
• How will market shares of each nasal drug delivery technology submarket develop from 2020-2030?
• Which individual technologies will prevail and how will these shifts be responded to?
• Which nasal drug delivery technology submarket will be the main driver of the overall market from 2020-2030?
• Will leading national nasal drug delivery technology markets broadly follow macroeconomic dynamics, or will individual country sectors outperform the rest of the economy?
• How will market shares of the national markets change by 2030 and which nation will lead the market in 2030?
• Who are the leading players and what are their prospects over the forecast period?
• How will the sector evolve as alliances form during the period between 2020 and 2030?

Visiongain's study is intended for anyone requiring commercial analyses for the Global Nasal Drug Delivery Technology Market. You find data, trends and predictions.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Cancer Diagnostics Market Report 2021-2031

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.

19 April 2021

Read

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

Read

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

Read

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever